- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01472250
A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China
This is a multi-center, prospective and observational clinical study. Eligible patients will accept generalized chemotherapy according to the investigator's assessment. Information related to the treatment, including medication, disease condition, expenses, etc. will be periodically collected. Follow-up at 2-month intervals will be periodically performed to continually collect information about the disease progression, subsequent treatment and survival until death or completion of the study.
Recruited patients will fill out questionnaires about quality of life before initiation of treatment, at Cycle 3 and completion of first-line treatment.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Beijing
-
Beijing, Beijing, Kina, 100142
- Lin Shen
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- The patient has histologically confirmed locally-advanced or recurrent and/or metastatic gastric or esophagogastric junction adenocarcinoma, has missed the opportunity of surgical excision, making curative therapy impossible.
- The informed consent form is signed.
- A specimen of tumor tissue (puncture biopsy or surgical specimen) is available.
- ECOG performance status is 0, 1 or 2.
- The patient's general conditions and functions of important organs allow generalized chemotherapy according to the investigator's judgment
- The patient is aged≥18
Exclusion Criteria:
- The patient is known to be allergic to any study drug.
- The patient is recruited in other clinical study or is planned to participate into other clinical study.
- The patient has previously accepted chemotherapy against advanced or metastatic diseases (the patient may be recruited if the previous adjuvant therapy/neoadjuvant therapy was completed more than 6 months before inclusion).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
chemotherapy
Eligible patients will accept generalized chemotherapy according to the investigator's assessment.
|
Clinical drugs will be selected by the investigator according to recommendations in Chinese and foreign guidelines and depending on clinical experience and the patient's individual conditions, including but not limited to the drugs listed below: Platinum products: oxaliplatin, cisplatin Fluorouracil products: 5-fluorouracil, capecitabine, TS-1 Taxanes: paclitaxel, docetaxel |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
chemotherapy regimen
Tidsramme: 2 months
|
To evaluate the treatment model (singel or doublet or triplet chemotherapy)of patients with advanced gastric cancer in China
|
2 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
overall survival
Tidsramme: 2 months
|
OS means that from the first dose of treatment drug to death or lost, the follow-up visit will be performed every 2 months till death or lost
|
2 months
|
quality of life
Tidsramme: 6 weeks
|
To evaluate the quality of life before and after chemotherapy of Chinese patients in real clinical practice
|
6 weeks
|
treatment expense
Tidsramme: 2 months
|
To evaluate the treatment expense of first-line treatment of Chinese patients with advanced gastric cancer in real clinical practice
|
2 months
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CGOG1002
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Avansert magekreft
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)FullførtRoux-en-Y Gastric Bypass | Bariatrisk kirurgi | Vertical Sleeve Gastrectomy | Magebånd | Bypass, GastricForente stater
-
Providence Health & ServicesTilgjengeligKRAS G12V Mutant Advanced Epithelial Cancers
-
Medtronic - MITGFullført
-
North Dakota State UniversityNational Institutes of Health (NIH)FullførtRoux en Y Gastric Bypass kirurgiForente stater
-
DuomedAktiv, ikke rekrutterendeOvervekt | Gastrectomi | Roux-en-Y Gastric Bypass | Mini Gastric BypassBelgia
-
Shanghai Pudong HospitalUTC Therapeutics Inc.TilbaketrukketMesothelin-positive Advanced Refractory Solid TumorsKina
-
Wageningen UniversityRijnstate HospitalUkjentRoux-en-Y Gastric BypassNederland
-
North Dakota State UniversityNeuropsychiatric Research Institute, Fargo, North DakotaFullførtRoux en Y Gastric BypassForente stater
-
Olympus Corporation of the AmericasUnity Health TorontoFullført
-
Novartis PharmaceuticalsFullførtcMET Dysegulation Advanced Solid TumorsØsterrike, Danmark, Sverige, Storbritannia, Spania, Tyskland, Nederland, Forente stater
Kliniske studier på Clinical chemo-drugs
-
Madigan Army Medical CenterTelemedicine & Advanced Technology Research Center; Analytics4Medicine,...Ukjent
-
Thomas Jefferson UniversityFullførtHematopoetisk og lymfoid celle-neoplasma | Ondartet fast neoplasmaForente stater
-
BC Centre for Improved Cardiovascular HealthUniversity of British ColumbiaUkjent
-
University of MiamiRekruttering
-
Linkoeping UniversityAktiv, ikke rekrutterendeHjerteinfarkt | SkrøpelighetSverige
-
University of SaskatchewanNovartis; Lung Association of SaskatchewanUkjentLungesykdom, kronisk obstruktivCanada
-
NuvoAir Medical PCRekrutteringKOLS | Komorbiditeter og sameksisterende tilstanderForente stater
-
University of North Carolina, Chapel HillNational Institute of Environmental Health Sciences (NIEHS)FullførtFriske voksneForente stater
-
NYU Langone HealthUnited States Department of DefenseFullført
-
Aifred HealthMcGill UniversityFullført